¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö : 2021-12-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö : 2021-12-02
±³À°ÀÏÀÚ : 2021-12-02
±³À°Àå¼Ò : ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 1Ãþ ¼¼¹Ì³ª½Ç  
±³À°ÁÖÁ¦ : 2021 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : È£³² Áöȸ  
´ã´çÀÚ : ±è⼺
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : laminion@hanmail.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 16:00~16:15 Clinical characteristics of acute kidney injury in patients with glyphosate surfactant herbicide intoxication  Á¶¾Æ¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 16:15~16:30 Potassium intake, blood pressure variability and cardiovascular outcomes in chronic kidney disease  ¼­»óÇå(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 16:30~16:45 Light chain deposition disease in kidney transplantation  ½Åº´Ã¶(Á¶¼±ÀÇ´ë) 
Åä·Ð 12-02 ¼¼¹Ì³ª½Ç 16:45~17:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Clinical outcomes of chronic kidney disease)  À̽Ä,±è⼺,ÃÖÈ«»ó(ÀüºÏÀÇ´ë,Àü³²ÀÇ´ë,Àü³²ÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 17:00~17:20 Effects of probiotics, prebiotics, and synbiotics on uremic toxins, inflammation and oxidative stress in HD patients  ±èÇü¿Ï(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 17:20~17:40 Plasma sclerostin level associated with use of MCO dialyzer in ESRD patients (2 year study)  Á¤Á¾È¯(¿ø±¤ÀÇ´ë) 
Åä·Ð 12-02 ¼¼¹Ì³ª½Ç 17:40~18:00 ÆгÎÅäÀÇ(ÁÖÁ¦: Biomarkers of ESRD)  ±èÇö¸®,¹èÀºÈñ,¿ÀÅ·Å(Á¶¼±ÀÇ´ë,Àü³²ÀÇ´ë,Àü³²ÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 18:00~18:25 ¿ä¾çº´¿ø¿¡¼­ Åõ¼® ȯÀÚº¸±â  ¼ÛÁÖÈ«(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 18:25~18:50 ¸ð¹ü»ýº¸´Ù ¸ðÇè»ýÀ»  ¹Ú¼º±¤(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 12-02 ¼¼¹Ì³ª½Ç 18:50~19:15 God committee/David & Goliath  À̱¤¿µ(ÀüÁÖ¿¹¼öº´¿ø) 
Åä·Ð 12-02 ¼¼¹Ì³ª½Ç 19:15~19:30 ÆгÎÅäÀÇ(ÁÖÁ¦: Emerging problems of ethical conflict)  ¾È¼±È£,°­°æÇ¥,¼±ÀοÀ(¿ø±¤ÀÇ´ë,ÀüºÏÀÇ´ë,ÀüÁÖ¿¹¼öº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021 ´ëÇѽÅÀåÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö : 2021-12-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÇ»ç¸éÇã°ü¸®Á¦µµ, ÇâÈÄ ¾î¶»°Ô °ü¸®µÇ¾î¾ß Çϴ°¡? : 2021-12-02
´ÙÀ½±Û ¼­¿ï´ëÇб³º´¿ø 2021³â °íÀ§Çè »ê¸ð ∙ ½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ Á¦ 2ȸ ½ÉÆ÷Áö¾ö: °íÀ§Çè »ê¸ð∙ ½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ »ç¾÷ÀÇ ÇâÈÄ ¹ßÀü ¹æÇâ : 2021-12-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 2 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 5 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 3 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 4 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 3 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 6 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 1 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 1 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 3 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 4 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 6 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷